מאמרים עם הרשאות לגישה ציבורית - Frederic H Menkoלמידע נוסף
לא זמינים באתר כלשהו: 6
The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice
FH Menko, JA Ter Stege, LE van der Kolk, KN Jeanson, W Schats, ...
Familial cancer 18, 127-135, 2019
הרשאות: Dutch Cancer Society
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
RM Brohet, ME Velthuizen, FBL Hogervorst, HEJ Meijers-Heijboer, ...
Journal of medical genetics 51 (2), 98-107, 2014
הרשאות: Cancer Research UK, Dutch Cancer Society
How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial
W Eijzenga, E de Geus, CM Aalfs, FH Menko, RH Sijmons, ...
Patient education and counseling 101 (9), 1611-1619, 2018
הרשאות: Dutch Cancer Society
Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment
J Vos, FH Menko, JC Oosterwijk, CJ van Asperen, AM Stiggelbout, ...
Psycho‐Oncology 22 (5), 1167-1176, 2013
הרשאות: Dutch Cancer Society
New developments in the pathogenesis of pulmonary cysts in Birt–Hogg–Dubé syndrome
JC Kennedy, D Khabibullin, Y Boku, W Shi, EP Henske
Seminars in Respiratory and Critical Care Medicine 41 (02), 247-255, 2020
הרשאות: US National Institutes of Health
The Inaugural Birt-Hogg-Dubé (BHD) Symposium
E Maher, F Menko, L Schmidt, J Toro, M van Steensel
Familial Cancer 7, S1-S11, 2008
הרשאות: US National Institutes of Health
זמינים באתר כלשהו: 16
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment
FH Menko, ER Maher, LS Schmidt, LA Middelton, K Aittomäki, I Tomlinson, ...
Familial cancer 13, 637-644, 2014
הרשאות: US National Institutes of Health, Wellcome Trust
Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk
SW Ten Broeke, RM Brohet, CM Tops, HM van der Klift, ME Velthuizen, ...
Journal of Clinical Oncology 33 (4), 319-325, 2015
הרשאות: Dutch Cancer Society
Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families
AC Houweling, LM Gijezen, MA Jonker, MBA van Doorn, RA Oldenburg, ...
British journal of cancer 105 (12), 1912-1919, 2011
הרשאות: Myrovlytis Trust, UK
Birt–Hogg–Dube syndrome is a novel ciliopathy
MNH Luijten, SG Basten, T Claessens, M Vernooij, CL Scott, R Janssen, ...
Human molecular genetics 22 (21), 4383-4397, 2013
הרשאות: Myrovlytis Trust, UK, Wellcome Trust, Worldwide Cancer Research, UK, Dutch …
Topical rapamycin as a treatment for fibrofolliculomas in Birt-Hogg-Dubé syndrome: a double-blind placebo-controlled randomized split-face trial
LMC Gijezen, M Vernooij, H Martens, CEU Oduber, CJM Henquet, ...
PloS one 9 (6), e99071, 2014
הרשאות: Myrovlytis Trust, UK, Dutch Cancer Society
Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity
H Houlleberghs, A Goverde, J Lusseveld, M Dekker, MJ Bruno, FH Menko, ...
PLoS genetics 13 (5), e1006765, 2017
הרשאות: Dutch Cancer Society
Colorectal cancer risk variants on 11q23 and 15q13 are associated with unexplained adenomatous polyposis
FJ Hes, D Ruano, M Nieuwenhuis, CM Tops, M Schrumpf, M Nielsen, ...
Journal of medical genetics 51 (1), 55-60, 2014
הרשאות: Worldwide Cancer Research, UK, Dutch Cancer Society
Design and feasibility of an intervention to support cancer genetic counselees in informing their at-risk relatives
E de Geus, W Eijzenga, FH Menko, RH Sijmons, HCJM de Haes, ...
Journal of genetic counseling 25, 1179-1187, 2016
הרשאות: Dutch Cancer Society
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers
M Suerink, HM Van Der Klift, SW Ten Broeke, OM Dekkers, I Bernstein, ...
Genetics in Medicine 18 (4), 405-409, 2016
הרשאות: Dutch Cancer Society
A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation
FH Menko, PC Johannesma, RJA van Moorselaar, R Reinhard, ...
Familial cancer 12, 373-379, 2013
הרשאות: Dutch Cancer Society
Development of the informing relatives inventory (IRI): assessing index Patients’ knowledge, motivation and self-efficacy regarding the disclosure of hereditary Cancer risk …
E de Geus, CM Aalfs, FH Menko, RH Sijmons, MGE Verdam, ...
International journal of behavioral medicine 22, 551-560, 2015
הרשאות: Dutch Cancer Society
The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trial
L Henneman, JC Oosterwijk, CJ van Asperen, FH Menko, ...
BMC medical informatics and decision making 13, 1-9, 2013
הרשאות: Dutch Cancer Society
Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair
EAL Wielders, J Hettinger, R Dekker, CM Kets, MJ Ligtenberg, ...
Journal of medical genetics 51 (4), 245-253, 2014
הרשאות: Dutch Cancer Society
Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers
Z Ghorbanoghli, MH Nieuwenhuis, JJ Houwing-Duistermaat, ...
Familial Cancer 15, 563-570, 2016
הרשאות: Dutch Cancer Society
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב